Towards Characteristics of Photodynamic Drugs Specifically Aimed at Microvascular Diseases
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
10
Page:
332-341
Author(s):
Jingquan Zhao, Hong Deng, Jie Xie, Xin Liu, Yang Zhang, Naiyan Huang and Ying Gu
Specific Immune Intervention with Monoclonal Antibodies for the Treatment of Multiple Sclerosis
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
640-650
Author(s):
Corinna Trebst, Elke Voß, Thomas Skripuletz and Martin Stangel
The Bcl-2 Family as a Rational Target for the Treatment of B-Cell Chronic Lymphocytic Leukaemia
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
801-811
Author(s):
N. Capitani and C. T. Baldari
Advances in Biologic Agents for the Treatment of Rheumatoid Arthritis
Journal:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume:
9
Page:
24-34
Author(s):
Ali Gur and Pelin Oktayoglu
Statins as Either Immunomodulators or Anti-Cancer Drugs: Functional Activities on Tumor Stromal Cells and Natural Killer Cells
Journal:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume:
9
Page:
82-92
Author(s):
Alessandro Poggi, Alessandra Musso, Silvia Boero, Paolo Canevali and Maria Raffaella Zocchi
Future Prospect of RNA Interference for Cancer Therapies
Journal:
Current Drug Targets
Volume:
11
Page:
345-360
Author(s):
Eishi Ashihara, Eri Kawata and Taira Maekawa
Valproic Acid in the Complex Therapy of Malignant Tumors
Journal:
Current Drug Targets
Volume:
11
Page:
361-379
Author(s):
J. Hrebackova, J. Hrabeta and T. Eckschlager
Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
236-249
Author(s):
Mangeng Cheng and Gregory R. Ott
Development of Agents that Modulate Protein-Protein Interactions in Membranes
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1055-1062
Author(s):
Tina X. Zhao, Alexander J. Martinko, Vy H. Le, Jing Zhao and Hang Yin
Peptides Targeting Toll-Like Receptor Signalling Pathways for Novel Immune Therapeutics
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1063-1080
Author(s):
Rosa P. Gomariz, Irene Gutierrez-Canas, Alicia Arranz, Mar Carrion, Yasmina Juarranz, Javier Leceta and Carmen Martinez